Literature DB >> 10603364

Invasion and intracellular survival of Burkholderia cepacia.

D W Martin1, C D Mohr.   

Abstract

Burkholderia cepacia has emerged as an important pulmonary pathogen in immunocompromised patients and in patients with cystic fibrosis (CF). Little is known about the virulence factors and pathogenesis of B. cepacia, although the persistent and sometimes invasive infections caused by B. cepacia suggest that the organism possesses mechanisms for both cellular invasion and evasion of the host immune response. In this study, cultured human cells were used to analyze the invasion and intracellular survival of B. cepacia J2315, a highly transmissible clinical isolate responsible for morbidity and mortality in CF patients. Quantitative invasion and intracellular growth assays demonstrated that B. cepacia J2315 was able to enter, survive, and replicate intracellularly in U937-derived macrophages and A549 pulmonary epithelial cells. Transmission electron microscopy of infected macrophages confirmed the presence of intracellular B. cepacia and showed that intracellular bacteria were contained within membrane-bound vacuoles. An environmental isolate of B. cepacia, strain J2540, was also examined for its ability to invade and survive intracellularly in cultured human cells. J2540 entered cultured macrophages with an invasion frequency similar to that of the clinical strain, but it was less invasive than the clinical strain in epithelial cells. In marked contrast to the clinical strain, the environmental isolate was unable to survive or replicate intracellularly in either cultured macrophages or epithelial cells. Invasion and intracellular survival may play important roles in the ability of virulent strains of B. cepacia to evade the host immune response and cause persistent infections in CF patients.

Entities:  

Mesh:

Year:  2000        PMID: 10603364      PMCID: PMC97097          DOI: 10.1128/IAI.68.1.24-29.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  A single genetic locus encoded by Yersinia pseudotuberculosis permits invasion of cultured animal cells by Escherichia coli K-12.

Authors:  R R Isberg; S Falkow
Journal:  Nature       Date:  1985 Sep 19-25       Impact factor: 49.962

Review 2.  Immunity to intracellular bacteria.

Authors:  S H Kaufmann
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

3.  In vitro activities of meropenem, PD 127391, PD 131628, ceftazidime, chloramphenicol, co-trimoxazole, and ciprofloxacin against Pseudomonas cepacia.

Authors:  C Lewin; C Doherty; J Govan
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

4.  Pneumonia and septicemia due to Pseudomonas cepacia in a patient with cystic fibrosis.

Authors:  B J Rosenstein; D E Hall
Journal:  Johns Hopkins Med J       Date:  1980-11

5.  Coated pits, coated vesicles, and receptor-mediated endocytosis.

Authors:  J L Goldstein; R G Anderson; M S Brown
Journal:  Nature       Date:  1979-06-21       Impact factor: 49.962

6.  Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.

Authors:  A Isles; I Maclusky; M Corey; R Gold; C Prober; P Fleming; H Levison
Journal:  J Pediatr       Date:  1984-02       Impact factor: 4.406

Review 7.  Microbiology of lung infection in cystic fibrosis.

Authors:  J R Govan; J W Nelson
Journal:  Br Med Bull       Date:  1992-10       Impact factor: 4.291

8.  Antibiotic resistance of Pseudomonas species.

Authors:  A Prince
Journal:  J Pediatr       Date:  1986-05       Impact factor: 4.406

9.  Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia.

Authors:  R Gold; E Jin; H Levison; A Isles; P C Fleming
Journal:  J Antimicrob Chemother       Date:  1983-07       Impact factor: 5.790

10.  Complement component C3 fixes selectively to the major outer membrane protein (MOMP) of Legionella pneumophila and mediates phagocytosis of liposome-MOMP complexes by human monocytes.

Authors:  C Bellinger-Kawahara; M A Horwitz
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

View more
  63 in total

Review 1.  Sequencing of the Pseudomonas aeruginosa and Burkholderia cepacia genomes and their applications in relation to cystic fibrosis.

Authors:  Deborah A Miller; Eshwar Mahenthiralingam
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

2.  Enhanced susceptibility to pulmonary infection with Burkholderia cepacia in Cftr(-/-) mice.

Authors:  U Sajjan; G Thanassoulis; V Cherapanov; A Lu; C Sjolin; B Steer; Y J Wu; O D Rotstein; G Kent; C McKerlie; J Forstner; G P Downey
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Localization of Burkholderia cepacia complex bacteria in cystic fibrosis lungs and interactions with Pseudomonas aeruginosa in hypoxic mucus.

Authors:  Ute Schwab; Lubna H Abdullah; Olivia S Perlmutt; Daniel Albert; C William Davis; Roland R Arnold; James R Yankaskas; Peter Gilligan; Heiner Neubauer; Scott H Randell; Richard C Boucher
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

4.  Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex.

Authors:  Adam Baldwin; Eshwar Mahenthiralingam; Kathleen M Thickett; David Honeybourne; Martin C J Maiden; John R Govan; David P Speert; John J Lipuma; Peter Vandamme; Chris G Dowson
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

5.  Isolation and culture of airway epithelial cells from chronically infected human lungs.

Authors:  S H Randell; L Walstad; U E Schwab; B R Grubb; J R Yankaskas
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-09       Impact factor: 2.416

6.  Characterization of BCAM0224, a multifunctional trimeric autotransporter from the human pathogen Burkholderia cenocepacia.

Authors:  Dalila Mil-Homens; Maria Inês Leça; Fábio Fernandes; Sandra N Pinto; Arsenio M Fialho
Journal:  J Bacteriol       Date:  2014-03-21       Impact factor: 3.490

7.  Burkholderia cenocepacia creates an intramacrophage replication niche in zebrafish embryos, followed by bacterial dissemination and establishment of systemic infection.

Authors:  Annette C Vergunst; Annemarie H Meijer; Stephen A Renshaw; David O'Callaghan
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

8.  Role of lipase in Burkholderia cepacia complex (Bcc) invasion of lung epithelial cells.

Authors:  T Mullen; K Markey; P Murphy; S McClean; M Callaghan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-12       Impact factor: 3.267

9.  Energy-generating enzymes of Burkholderia cepacia and their interactions with macrophages.

Authors:  Vasu Punj; Rachna Sharma; Olga Zaborina; A M Chakrabarty
Journal:  J Bacteriol       Date:  2003-05       Impact factor: 3.490

10.  A type IV secretion system contributes to intracellular survival and replication of Burkholderia cenocepacia.

Authors:  S Umadevi Sajjan; Lisa A Carmody; Carlos F Gonzalez; John J LiPuma
Journal:  Infect Immun       Date:  2008-09-29       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.